Allergan
This article was originally published in The Tan Sheet
Executive Summary
Corporate restructuring should not affect its lens care solution business, the company says. Allergan announced Sept. 15 it will be closing five manufacturing plants and reducing its workforce by 550 people over the next three years. The changes are part of an "operational efficiency initiative" designed to move the firm "into the ranks of top-quartile performing companies," Allergan said. For the six months ended June 26, the company lost $87.4 mil
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: